Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) EPS (Weighted Average and Diluted) (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.97 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 20.49% year-over-year to $0.97; the TTM value through Dec 2025 reached $3.79, down 11.24%, while the annual FY2025 figure was $4.29, 2.88% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.97 in Q4 2025 per PBH's latest filing, up from $0.86 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.22 in Q4 2024 and bottomed at -$4.79 in Q1 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.72, with a median of $1.02 recorded in 2022.
  • Peak YoY movement for EPS (Weighted Average and Diluted): crashed 569.61% in 2023, then soared 120.46% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.99 in 2021, then rose by 5.05% to $1.04 in 2022, then increased by 1.92% to $1.06 in 2023, then increased by 15.09% to $1.22 in 2024, then decreased by 20.49% to $0.97 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.97 in Q4 2025, $0.86 in Q3 2025, and $0.95 in Q2 2025.